Screening of differentially expressed genes related to severe sepsis induced by multiple trauma with DNA microarray

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 5, 2014, Pages 734-739

  Shen, Z G ^a   Guo, J L ^a   Li, D S ^a  

^a TONGJI HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

Differentially expressed gene; GO enrichment analysis; Interaction network; Pathway analysis; Trauma complicated by sepsis

Indexed keywords

NEUTROPHIL COLLAGENASE; PROTEINASE INHIBITOR; UROKINASE; TRANSCRIPTOME;

ARTICLE; COMPUTER PROGRAM; DATA BASE; DISEASE SEVERITY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GENE IDENTIFICATION; MULTIPLE TRAUMA; SEPSIS; UPREGULATION; WOUND; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETIC SCREENING; GENETICS; HUMAN; MALE; PHYSIOLOGY; PROCEDURES;

FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENETIC TESTING; HUMANS; MALE; MULTIPLE TRAUMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SEPSIS; TRANSCRIPTOME; UP-REGULATION;

EID: 84896941566     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. OSBORN TM, TRACY JK, DUNNE JR, PASQUALE M, NAPOLITANO LM. Epidemiology of sepsis in patients with traumatic injury. Crit Care Med 2004; 32: 2234-2240.
2. WAFAISADE A, LEFERING R, BOUILLON B, SAKKA SG, THAMM OC, PAFFRATH T, NEUGEBAUER E, MAEGELE M; Trauma Registry of the German Society for Trauma Surgery. Epidemiology and risk factors of sepsis after multiple trauma: an analysis of 29,829 patients from the Trauma Registry of the German Society for Trauma Surgery. Crit Care Med 2011; 39: 621-628.
3. INGRAHAM AM, XIONG W, HEMMILA MR, SHAFI S, GOBLE S, NEAL ML, NATHENS AB. The attributable mortality and length of stay of trauma-related complications: a matched cohort study. Ann Surg 2010; 252: 358-362.
4. KISAT M, VILLEGAS CV, ONGUTI S, ZAFAR SN, LATIF A, EFRON DT, HAUT ER, SCHNEIDER EB, LIPSETT PA, ZAFAR H, HAIDER AH. Predictors of sepsis in moderately severely injured patients: an analysis of the National Trauma Data Bank. Surg Infect 2013; 14: 62-68.
5. LENZ A, FRANKLIN GA, CHEADLE WG. Systemic inflammation after trauma. Injury 2007; 38: 1336-1345.
6. HOTCHKISS RS, NICHOLSON DW. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 2006; 6: 813-822.
7. RITTIRSCH D, FLIERL MA, WARD PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol 2008; 8: 776-787.
8. JEAN-BAPTISTE E. Cellular mechanisms in sepsis. J Intensive Care Med 2007; 22: 63-72.
9. RITTIRSCH D, FLIERL MA, NADEAU BA, DAY DE, HUBERLANG M, MACKAY CR, ZETOUNE FS, GERARD NP, CIANFLONE K, KÖHL J, GERARD C, SARMA JV, WARD PA. Functional roles for C5a receptors in sepsis. Nat Med 2008; 14: 551-557.
10. WANG H, LIAO H, OCHANI M, JUSTINIANI M, LIN X, YANG L, AL-ABED Y, WANG H, METZ C, MILLER EJ, TRACEY KJ, ULLOA L. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 2004; 10: 1216-1221.
11. UZZAN B, COHEN R, NICOLAS P, CUCHERAT M, PERRET G-Y. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006; 34: 1996-2003.
12. GIBOT S, KOLOPP-SARDA M-N, BÉNÉ MC, CRAVOISY A, LEVY B, FAURE GC, BOLLAERT PE. Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 2004; 141: 9-15.
13. PAVCNIK-ARNOL M, HOJKER S, DERGANC M. Lipopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children. Intensive Care Med 2007; 33: 1025-1032.
14. MORGENTHALER NG, STRUCK J, CHRIST-CRAIN M, BERGMANN A, MÜLLER B. Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. Crit Care 2004; 9: R37.
15. TROYANSKAYA O, CANTOR M, SHERLOCK G, BROWN P, HASTIE T, TIBSHIRANI R, BOTSTEIN D, ALTMAN RB. Missing value estimation methods for DNA microarrays. Bioinformatics 2001; 17: 520-525.
16. FUJITA A, SATO J, RODRIGUES L, FERREIRA C, SOGAYAR M. Evaluating different methods of microarray data normalization. BMC Bioinformatics 2006; 7: 469.
17. SMYTH GK. Limma: linear models for microarray data. Bioinformatics and computational biology solutions using R and Bioconductor: Springer 2005; pp. 397-420.
18. BENJAMINI Y, HOCHBERG Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc Series B 1995;57: 289-300.
19. HOSACK DA, DENNIS JR G, SHERMAN BT, LANE HC, LEMPICKI RA. Identifying biological themes within lists of genes with EASE. Genome Biol 2003; 4: R70.
20. PATIL A, NAKAI K, NAKAMURA H. HitPredict: a database of quality assessed protein-protein interactions in nine species. Nucleic Acids Res 2011; 39: D744-D749.
21. DUNCAN D, PRODDUTURI N, ZHANG B. WebGestalt2: an updated and expanded version of the Web based Gene Set Analysis Toolkit. BMC Bioinformatics 2010; 11: P10.
22. ZHANG B, KIROV S, SNODDY J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 2005; 33: W741-W748.
23. HASTY K, JEFFREY J, HIBBS M, WELGUS H. The collagen substrate specificity of human neutrophil collagenase. J Biol Chem 1987; 262: 10048-10052.
24. MANICONE AM, MCGUIRE JK. Matrix metalloproteinases as modulators of inflammation. Sem Cell Develop Biol 2008; 19: 34-41.
25. COX JH, STARR AE, KAPPELHOFF R, YAN R, ROBERTS CR, OVERALL CM. Matrix metalloproteinase 8 deficiency in mice exacerbates inflammatory ar thritis through delayed neutrophil apoptosis and reduced caspase 11 expression. Arthritis Rheum 2010; 62: 3645-3655.
26. GUTIÉRREZ-FERNÁNDEZ A, INADA M, BALBÍN M, FUEYO A, PITIOT AS, ASTUDILLO A, HIROSE K, HIRATA M, SHAPIRO SD, NOËL A, WERB Z, KRANE SM, LÓPEZ-OTÍN C, PUENTE XS. Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8). FASEB J 2007; 21: 2580-2591.
27. LAUHIO A, HÄSTBACKA J, PETTILÄ V, TERVAHARTIALA T, KARLSSON S, VARPULA T, VARPULA M, RUOKONEN E, SORSA T, KOLHO E. Serum MMP-8,-9 and TIMP-1 in sepsis: high serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines. Pharmacol Res 2011; 64: 590-594.
28. SOLAN PD, DUNSMORE KE, DENENBERG AG, ODOMS K, ZINGARELLI B, WONG HR. A novel role for matrix metalloproteinase-8 in sepsis. Crit Care Med 2012; 40: 379-387.
29. CARMELIET P, MOONS L, LIJNEN R, BAES M, LEMAÎTRE V, TIPPING P, DREW A, EECKHOUT Y, SHAPIRO S, LUPU F, COLLEN D. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet 1997; 17: 439-444.
30. ABRAHAM E, GYETKO MR, KUHN K, ARCAROLI J, STRASSHEIM D, PARK JS, SHETTY S, IDELL S. Urokinasetype plasminogen activator potentiates lipopolysaccharide- induced neutrophil activation. J Immunol 2003; 170: 5644-5651.
31. ROBBIE L, DUMMER S, BOOTH N, ADEY G, BENNETT B. Plasminogen activator inhibitor 2 and urokinasetype plasminogen activator in plasma and leucocytes in patients with severe sepsis. Br J Haematol 2000; 109: 342-348.
32. ESMON CT. The impact of the inflammatory response on coagulation. Thromb Res 2004; 114: 321-327.
33. KREM MM, CERA ED. Evolution of enzyme cascades from embryonic development to blood coagulation. Trends Biochem Sci 2002; 27: 67-74.